PMA device
Simplera System
Medtronic Minimed · Sensor, Glucose, Invasive, Non-Adjunctive (PQF, Class III) · First FDA decision Jul 24, 2024, newest Jul 24, 2024Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
5
Naming "Simplera"
MAUDE reports
5,109
Brand "Simplera", since 2015
PubMed studies
13
Mentioning "Simplera"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Simplera System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Simplera SystemPMA supplement
P160007-S047 · Decided Jul 24, 2024 · 525 days after receipt · Panel Track
Device type: Sensor, glucose, invasive, non-adjunctive (PQF) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Simplera", any status and sponsor, newest update first.
- Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With DiabetesPivotal-lookingRecruiting
CAPTEUR PROTECTNot on our public-company list
NCT07018180 · 194 participants (planned) · Start Dec 5, 2025
Device: Use of COVER patchs for continuous glucose monitoring sensor · For: Diabetes
Sites: Bron, France; Corbeil-Essonnes, France; Grenoble, France · 10 sites in all
- GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesPivotal-lookingActive, not recruiting
Medtronic MiniMed, Inc.Public (MDT)
NCT07228117 · 389 participants · Start Feb 2, 2026 · Primary completion Jan 2027
Device: MiniMed™ NMX8-AID System with DS5™/Simplera Sync™ · For: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
Sites: Little Rock, Arkansas; Escondido, California; Goleta, California · 33 sites in all
Centre Hospitalier Sud FrancilienAcademic, hospital or other
NCT07430293 · 24 participants (planned) · Start May 19, 2026 · Primary completion Nov 19, 2027
Device: MiniMed 780 associated with Simplera · For: Pancreatectomy; Total Pancreatectomy; Partial Pancreatectomy
Sites: Corbeil-Essonnes, France; Paris, France
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Simplera", and for the whole product code for context.
This brand
5,109 reports: 5,014 malfunction, 95 injury, 0 death
Whole product code PQF
328,575 reports: 326,235 malfunction, 2,330 injury, 10 death
Newest reports for this brand
- SENSOR MMT-5100JD1 SIMPLERA 1PK OUS1Malfunction
2032227-2026-264261 · Received Oct 30, 2026 · Event dated Oct 22, 2026
Device type: Sensor, Glucose, Invasive, Non-Adjunctive (PQF)
Device problem as coded: Wireless Communication Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SENSOR MMT-5120B SIMPLERA SYNC 1PK USMalfunction
Medtronic Puerto Rico Operations Co.
2032227-2026-264296 · Received Oct 30, 2026 · Event dated Oct 17, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Wireless Communication Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SENSOR MMT-5120B SIMPLERA SYNC 1PK USMalfunction
2032227-2026-264301 · Received Oct 30, 2026 · Event dated Oct 18, 2026
Device type: Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System (SFI)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings; Calibration Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Medtronic, Simplera Sensor, REF: MMT-5100JD1Open, Classified
Z-0033-2026 · Started May 7, 2025 · Posted by FDA Oct 2, 2025
Reason given: The device cap label may not adhere to the sensor, compromising the sterility of the sensor, and increasing the risk of infection.
Cause as FDA categorized it: Process design · Device type: Sensor, Glucose, Invasive (MDS)
- Guardian Connect App CSS7200 iOS and Guardian Connect Transmitter GST4C used on the iPhone, iPad and iPod Touch devices.Open, Classified
Z-2106-2020 · Started May 20, 2019
Reason given: Customers using the firm's continuous glucose monitoring system application on an iPhone, iPad or iPod Touch with ios software version 12, 12.1, or 12,2 are likely to experience a shortened transmitter battery life (approximately 4-5 days instead of the normal 7 days or more) after a full charge.
Cause as FDA categorized it: Software design · Device type: Sensor, Glucose, Invasive (MDS)
Z-1282-2019 · Started Jul 4, 2018
Reason given: The application may be closed by the operating system without alerting the user the app is no longer running or communicating with the transmitter resulting in the user not receiving alerts that could be associated with hypoglycemic or hyperglycemic events.
Cause as FDA categorized it: Software design · Device type: Sensor, Glucose, Invasive (MDS)
Published research
The most relevant PubMed records for "Simplera"[tiab]. The summary above synthesizes these.
- A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems.
Freckmann G, Wehrstedt S, Eichenlaub M, et al. · Diabetes Care · 2025Comparative Study
- Performance of continuous glucose monitoring systems (CGMs) during commercial flights in T1DM: A within-subject comparative pilot study.
Meçani R, Basta S, Baumann PM, et al. · Diabetes Obes Metab · 2026Comparative Study
- Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor.
Nally LM, Sherr JL, Garg SK, et al. · Diabetes Technol Ther · 2026Multicenter Study, Research Support, Non-U.S. Gov't
- Performance of three simultaneously used rtCGM systems around a physically active weekend camp in adults with type 1 diabetes: A prospective lab and real-world study.
Sanfilippo S, Thurm U, Renfordt M, et al. · Diabetes Obes Metab · 2026
- Performance of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes.
Eichenlaub M, Waldenmaier D, Wehrstedt S, et al. · J Diabetes Sci Technol · 2026Comparative Study
- Glycemic Concordance of Simplera Syncࡊ and Instinctࡊ Sensors in MiniMedࡊ 780G System Users: A Randomized Crossover Feasibility Study.
Laron-Hirsh M, Barel S, Roy A, et al. · Diabetes Technol Ther · 2026Equivalence Trial, Randomized Controlled Trial
- Consistent efficacy and safety of automated insulin delivery in children aged 2-6 years: results from the LENNY trial continuation phase.
Dovc K, Tuomaala A, Kuusela S, et al. · Diabetes Res Clin Pract · 2025Randomized Controlled Trial, Equivalence Trial
- Insights into the effective use of the Smart MDI system: Data from the first 1852 type 1 diabetes users.
Laurenzi A, Edd SN, Adolfsson P, et al. · Diabet Med · 2025Multicenter Study
- Enhancing user experience with an automated insulin delivery system by upgrading to a next generation sensor.
Beato-Víbora PI, Gil-Poch E, Arroyo-Díez FJ · Diab Vasc Dis Res · 2026
- Experiences with Simplera syncࡊ all-in-one sensors and extended wear infusion sets in adolescents and young adults using the MiniMedࡊ 780G: A qualitative study.
Michaels VR, Crocket HR, Boucsein A, et al. · Diabet Med · 2026
- Impact of Simplera Syncࡊ sensors and Extendedࡊ Wear Infusion Sets on glycaemia and system performance of the MiniMedࡊ 780G system in children and young adults with previously high HbA1c.
Michaels VR, Boucsein A, Zhou Y, et al. · Diabet Med · 2025Randomized Controlled Trial
- All-in-one sensor design with overlapping sensor transition reduces automode interruptions and improves patient-reported outcomes in adolescents with type 1 diabetes: real-world evidence from simplera sync integration.
Marigliano M, Scaramuzza A, Bonfanti R, et al. · Diabetes Res Clin Pract · 2026
Other devices of this type
Also filed under product code PQF.
- Dexcom G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2019
- Dexcom G4 Platinum Contiuous Glucose Monitoring SystemDexcom, Inc. · PMA 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.